These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27346579)

  • 21. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400.
    Musshoff F; Wolters T; Lott S; Ippisch J; Gradl S; Madea B
    Drug Test Anal; 2013 May; 5(5):366-71. PubMed ID: 23386567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens.
    Hsu J; Liu C; Liu CP; Tsay WI; Li JH; Lin DL; Liu RH
    J Anal Toxicol; 2003 Oct; 27(7):471-8. PubMed ID: 14607002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multianalyte assay system developed for drugs of abuse.
    Parsons RG; Kowal R; LeBlond D; Yue VT; Neargarder L; Bond L; Garcia D; Slater D; Rogers P
    Clin Chem; 1993 Sep; 39(9):1899-903. PubMed ID: 8375068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a human on-site urine multidrug test for emergency use with dogs.
    Teitler JB
    J Am Anim Hosp Assoc; 2009; 45(2):59-66. PubMed ID: 19258416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the multiple drugs immunoassay test for rapid detection of drug abuse in postmortem urine.
    Srisont S; Chirachariyavej T; Peonim AV
    J Med Assoc Thai; 2010 Nov; 93(11):1301-9. PubMed ID: 21114210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of two immunoassay procedures for drug testing in hair samples.
    Musshoff F; Kirschbaum KM; Graumann K; Herzfeld C; Sachs H; Madea B
    Forensic Sci Int; 2012 Feb; 215(1-3):60-3. PubMed ID: 21601388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ; Pelders MG; Egberts AC
    J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication.
    Arndt T; Gierten B; Güssregen B; Werle A; Grüner J
    Forensic Sci Int; 2009 Jan; 184(1-3):e27-9. PubMed ID: 19084359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
    Crooks CR; Brown S
    J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of urinary drugs of abuse by a multianalyte capillary electrophoretic immunoassay.
    Caslavska J; Allemann D; Thormann W
    J Chromatogr A; 1999 Apr; 838(1-2):197-211. PubMed ID: 10327639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
    Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
    J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
    Moody DE; Fang WB; Andrenyak DM; Monti KM; Jones C
    J Anal Toxicol; 2006; 30(1):50-6. PubMed ID: 16620532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.
    Feng J; Wang L; Dai I; Harmon T; Bernert JT
    J Anal Toxicol; 2007 Sep; 31(7):359-68. PubMed ID: 17725883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.